BAPU ALURI: Open Payments
NPI 1487762456 · YUMA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,657 in 151 payments from 26 companies in 2025. Trend: 2023 $2,866 · 2024 $3,173 · 2025 $2,657
Food & beverage: $2,657
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $520 |
| Eisai Inc. | 10 | $251 |
| UCB, Inc. | 17 | $248 |
| Neurocrine BioSciences, Inc. | 15 | $195 |
| Mallinckrodt Hospital Products Inc. | 3 | $159 |
| Biogen, Inc. | 11 | $156 |
| ACADIA Pharmaceuticals Inc | 6 | $123 |
| Alexion Pharmaceuticals, Inc. | 4 | $102 |
| CATALYST PHARMACEUTICALS, INC. | 5 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
Products named: QULIPTA, Leqembi, Zilbrysq, INGREZZA, UBRELVY, ACTHAR, NUPLAZID, TYSABRI.
Industry payments across AZ — which companies pay providers there.
